Establishment Labs Holdings Inc.
A maker of breast implants and aesthetic medical devices, Establishment Labs produces the Motiva line of silicone-gel implants and the Motiva Flora tissue expander, sold in over 100 countries. Founded in 2004 by Juan José Chacón-Quirós, who started the company in his parents' house in Costa Rica, it became the first Costa Rican medtech firm to list on the Nasdaq in 2018. The Motiva brand name comes from the word "motive," reflecting the company's mission to put women's health first.
Sold 301.9K
Granted 27.2K · Sold 345.0K
Granted 264.8K · Bought 11.9K
Granted 49.9K
Granted 47.4K · Bought 2.9K
Granted 12.4K
Granted 13.4K
Granted 16.8K · Bought 2.3K
Granted 17.4K
Granted 12.5K
Granted 4.7K
Granted 7.4K
Granted 3.2K
| Insider | Stake change | Holds now | Granted / vested | Bought | Sold |
|---|---|---|---|---|---|
| Wild Jason G. +4 co-filersSee footnote 3 · 11 transactions | — | 15.02M | — | — | 301.9K |
| Chacon Quiros Juan JoseDirector · 31 transactions | — | 4.59M | 27.2K | — | 345.0K |
| Lewin Nicholas SheridanDirector · 19 transactions | +33.7% | 1.10M | 264.8K | 11.9K | — |
| Schutter Edward JDirector · 19 transactions | -41.4% | 177.7K | 49.9K | — | — |
| Caldini FilippoChief Executive Officer, Director · 7 transactions | — | 48.8K | 47.4K | 2.9K | — |
| Slotkin BryanDirector · 15 transactions | +61.7% | 32.6K | 12.4K | — | — |
| Custin AnnDirector · 13 transactions | +125.4% | 24.1K | 13.4K | — | — |
| Denhoy RajChief Financial Officer · 6 transactions | +298.3% | 23.3Kas of Mar 2025 | 16.8K | 2.3K | — |
| Mansbach Samuel RossGeneral Counsel and CCO · 6 transactions | +552.6% | 18.7K | 17.4K | — | — |
| Gillin LeslieDirector · 13 transactions | +210.6% | 18.4K | 12.5K | — | — |
| Condon Dennis EDirector · 6 transactions | +101% | 9.4Kas of Dec 2024 | 4.7K | — | — |
| Harris CassandraChief Financial Officer · 1 transaction | — | 7.4K | 7.4K | — | — |
| Harris Taylor C.Director · 2 transactions | — | 3.2K | 3.2K | — | — |
Select a row to see that insider’s individual transactions. Sum of the holdings confirmed in the 12 months before this insider's last filing. A Form 4 reports a holding per line — held directly, or through a named trust, partnership or foundation, and in each share class separately — never a person’s total. Lines not restated in that time are left out and shown apart: an active filer restates what they still hold, so a line they did not restate is more often an entity since renamed, whose shares a successor line reports too. An amber marker means some were left out.
Net open-market activity over the last 3 years: -629.9K shares. Grants, option exercises and tax withholding are excluded — they are compensation mechanics, not decisions to buy or sell.